Search for supersymmetry using razor variables in events with b-tagged jets in pp collisions at root s=8 TeV

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Searches for supersymmetry based on events with b jets and four W bosons in pp collisions at 8 TeV

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Observation of the rare B-s(0)->mu(+)mu(-) decay from the combined analysis of CMS and LHCb data

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C

Combined pegylated interferon (PegIFN) and ribavirin represents the standard therapy for patients with chronic hepatitis C (CHC), which allows for sustained viral response (SVR) in up to 90% of patients depending on certain viral and host factors. Clinical studies have demonstrated the importance of adherence to therapy, that is, the ability of patients to tolerate and sustain a fully dosed therapy regimen. Adherence is markedly impaired by treatment-related adverse effects. In particular, haemolytic anaemia often requires dose reduction or termination of ribavirin treatment, which compromises treatment efficacy. Recent evidence points to a beneficial role of recombinant erythropoietin (EPO) in alleviating ribavirin-induced anaemia thereby improving quality of life, enabling higher ribavirin dosage and consequently improving SVR. However, no general consensus exists regarding the use of EPO for specific indications: its optimal dosing, treatment benefits and potential risks or cost efficiency. The Swiss Association for the Study of the Liver (SASL) has therefore organized an expert meeting to critically review and discuss the current evidence and to phrase recommendations for clinical practice. A consensus was reached recommending the use of EPO for patients infected with viral genotype 1 developing significant anaemia below 100 g/L haemoglobin and a haematocrit of <30% during standard therapy to improve quality of life and sustain optimal ribavirin dose. However, the evidence supporting its use in patients with pre-existing anaemia, non-1 viral genotypes, a former relapse or nonresponse, liver transplant recipients and cardiovascular or pulmonary disease is considered insufficient.

Moses und Christus : oder üb. d. innern Werth u. d. wahrscheinl. Folgen d. Sendschreibens einiger Hausväter jüdischer Religion an Herrn Probst Teller u. dessen darauf ertheilte Antwort

[Benjamin Gottlob Gerlach]

Offene Antwort auf den offenen Brief des Herrn Rabbiners S. R. Hirsch an Herrn Rabbiner S. B.

von X.

Das Ceremonialgesetz im Messiasreich : als Vorläufer einer grössern Schrift üb. d. religiöse Reform d. Judenthums ; nebst e. krit. Abh. üb. d. Aufsatz: Reformbestrebungen u. Emancipation in d. Zeitschrift f. d. Interessen d. Judenthums

von Sam. Holdheim

Betrachtungen üb. die den Mosaismus u. die Neologie d. Rabbinen betr. königl. bayer. Ministerial-Entschliessung

von [Josef] Aub

Widerlegungen, ein Dialog üb. Herrn Hirsch's Mittheilungen aus Naphtali's Briefwechsel

hrsg. von [Josef] Aub

Jüdische Reformbestrebungen im 19. Jahrhundert : Vortr., geh. am 23 April 1907 im israel. Humanitätsvereine Wien B'nai B'rith

von Wilhelm Knöpfmacher

Traktat über die Neulichtbeobachtung und den Jahresbeginn bei den Karäern von Samuel b. Moses

nach e. arabischen Handschrift mit dem Fragmente e. hebräischen Übers. kritisch hrsg. u. ins Dt. übertr. von Felix Kauffmann